These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28423383)

  • 1. Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome.
    Hoppe RT
    Oncol Res Treat; 2017; 40(5):242-243. PubMed ID: 28423383
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the Committee on Therapy for Mycosis Fungoides and Sézary Syndrome.
    Minna JD; Roenigk HH; Glatstein E
    Cancer Treat Rep; 1979 Apr; 63(4):729-36. PubMed ID: 109209
    [No Abstract]   [Full Text] [Related]  

  • 3. New options in diagnosis and management of mycosis fungoides and Sézary syndrome.
    Enke CA
    Oncology (Williston Park); 2010 May; 24(6):507-8. PubMed ID: 20568591
    [No Abstract]   [Full Text] [Related]  

  • 4. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome.
    Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F
    Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycosis fungoides and the Sézary syndrome.
    Gisselbrecht C; Dubertret L
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total skin electron therapy of mycosis fungoides and the Sézary syndrome].
    Herbst M; Müller R
    Hautarzt; 1984 Jan; 35(1):16-21. PubMed ID: 6423569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
    Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of mycosis fungoides/Sezary syndrome: the University of California, San Francisco (UCSF) approach.
    Zackheim HS
    Int J Dermatol; 2003 Jan; 42(1):53-6. PubMed ID: 12581145
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome.
    Elsayad K; Stadler R; Steinbrink K; Eich HT
    J Dtsch Dermatol Ges; 2020 Mar; 18(3):193-197. PubMed ID: 32077638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.
    Molin S; Ruzicka T
    Br J Dermatol; 2009 Dec; 161(6):1420-2. PubMed ID: 19785592
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).
    Atilla E; Atilla PA; Bozdag SC; Yuksel MK; Toprak SK; Topcuoglu P; Akay BN; Sanli H; Gurman G; Ozcan M
    Int J Hematol; 2017 Sep; 106(3):426-430. PubMed ID: 28466385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we treat mycosis fungoides and Sézary syndrome.
    Khan N; Noor SJ; Horwitz S
    Clin Adv Hematol Oncol; 2021 Sep; 19(9):573-581. PubMed ID: 34495021
    [No Abstract]   [Full Text] [Related]  

  • 17. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M; Kadono T
    J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 19. Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome.
    Baron MK; Osborn JD; Tao R; Lee CJ
    Leuk Lymphoma; 2020 Jan; 61(1):231-233. PubMed ID: 31452419
    [No Abstract]   [Full Text] [Related]  

  • 20. A new nail in the CTCL coffin.
    Lessin SR
    J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.